Netrin-1 ameliorates myocardial infarction-induced myocardial injury: Mechanisms of action in rats and diabetic mice

Human Gene Therapy

Volumn 25, Issue 9, 2014, Pages 787-797

  Ke, Tingyu ^a   Wu, Yinxing ^b   Li, Li ^a   Liu, Yi ^b   Yao, Xinpeng ^b   Zhang, Jun ^b   Kong, Deling ^b,c   Li, Chen ^c  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; NETRIN 1; NITRIC OXIDE; PROTEIN P42; PROTEIN P44; NERVE GROWTH FACTOR; NETRIN-1; P44 PROTEIN, MOUSE; PEPTIDE FRAGMENT; PRIMER DNA; PROTEIN P53; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL MOBILIZATION; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PHOSPHORYLATION; PROCEDURES; RETROVIRIDAE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DNA PRIMERS; GENETIC VECTORS; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; NERVE GROWTH FACTORS; NITRIC OXIDE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS; THIAZOLES; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84907293423     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2014.021     Document Type: Article

References (45)

1. Aicher, A., Heeschen, C., Mildner-Rihm, C., et al. (2003). Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9, 1370-1376.
2. Arakawa, H. (2004). N etrin-1 and its receptors in tumorigenesis. Nat. Rev. Cancer 4, 978-987.
3. Bassi, E.J., Moraes-Vieira, P.M., Moreira-Sa, C.S., et al. (2012). Immune regulatory properties of allogeneic adiposederived mesenchymal s tem cells in the treatment of experimental autoimmune diabetes. Diabetes 61, 2534-2545.
4. Beltrami, A.P., Urbanek, K., Kajstura, J., et al. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750-1757.
5. Billon, N., Iannarelli, P., Monteiro, M.C., et al. (2007). The generation of adipocytes by the neural crest. Development 134, 2283-2292.
6. Cabou, C., Cani, P.D., Campistron, G., et al. (2007). Central insulin regulates heart rate and arterial blood flow: An endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes 56, 2872-2877.
7. Chen, J., Cai, Q.P., Shen, P.J., et al. (2012). Netrin-1 protects against L-arginine-induced acute pancreatitis in mice. PLoS One 7, e46201.
8. Cheng, Z., Ou, L.L., Zhou, X., et al. (2008). Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol. Ther. 16, 571-579.
9. Clay baugh, T., Decker, S., McCall, K., et al. (2014). l-Arginine supplementation in type II diabetic rats preserves renal function and improves insulin sensitivity by altering the nitric oxide pathway. Int. J. Endocrinol. 2014, 17 1546.
10. Constantin, G., Marconi, S., Rossi, B., et al. (2009). Adiposederived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27, 2624-2635.
11. Faucherre, A., and Jopling, C. (2013). The heart ?s contentrenewable resources. Int. J. Cardiol. 167, 1141-1146.
12. Figeac, F., Lesault, P.F., Le Coz, O., et al. (2014). Nanotubular crosstalk with distresse d cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells. Stem Cells 32, 216-230.
13. Fiorina, P., Jurewicz, M., Augello, A., et al. (2009). Immunomodulatory function of bone marr ow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J. Immunol. 183, 993-1004.
14. Fraser J.,Wulur I.,Alfonso Z.,et al., 2007, Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots, Cytotherapy, 9, 459-467.
15. Gnecchi, M., He, H., Liang, O.D., et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Aktmodified mesenchymal stem cells. Nat. Med. 11, 367-368.
16. Gomillion, C.T., and Burg, K.J. (2006). Stem cells and adipose tissue engineering. Biomaterials 27, 6052-6063.
17. Haffner, S.M., Leht o, S., Ronnemaa, T., et al. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339, 229-234.
18. Hebrok, M., and Reichardt, L.F. (2004). Brain meets pancreas: Netrin, an axon guidance molecule, controls epithelial cell migration. Trends Cell Biol. 14, 153-155.
19. Heeschen, C., Lehmann, R., Honold, J. , et al. (2004). Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109, 1615-1622.
20. Heydarkhan-Hagvall, S., Schenke-Layland, K., Yang, J.Q., et al. (2008). Human adipose stem cells: A potential cell source for cardiovascular tissue engineering. Cells Tissues Organs 187, 263-274.
21. Huang, M., Nguyen, P., J ia, F., et al. (2011). Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxiainducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation 124, S46-S54.
22. Lee, B.J., Wang, S.G., Lee, J.C., et al. (2006). The prevention of vocal fold scarring using autologous adipose tissue-derived stromal cells. Cells Tissues Organs 184, 198-204.
23. Liu, Y., Ye, X., Mao, L., et al. (2013). Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction. Cardiovasc. Res. 97, 208-218.
24. Ly, N.P., Komatsuzaki, K., Fraser, I.P., et al. (2005). Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 102, 14729-14734.
25. Mao, X., Xing, H., Mao, A., et al. (2014). Netrin-1 attenuates cardiac ischemia reperfusion injury and generates alternatively activated macrophages. Inflammation 37, 573-580.
26. Mirakaj, V., Thix , C.A., Laucher, S., et al. (2010). Netrin-1 dampens pulmonary inflammation during acute lung injury. Am. J. Respir. Crit. Care Med. 181, 815-824.
27. Park, B., Hoffman, A., Yang, Y., et al. (2010). End othelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice. J. Vasc. Surg. 51, 165-173.
28. Park, K.W., Crouse, D., Lee, M. , et al. (2004). The axonal attractant Netrin-1 is an angiogenic factor. Proc. Natl. Acad. Sci. U.S.A. 101, 16210-16215.
29. Polchert, D., Sobinsky, J., Douglas, G., et al. (2008). IFN-c activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur. J. Immunol. 38, 1745-1755.
30. Ptaszek, L.M., Mansour, M., Ruskin, J.N., and Chien, K.R. (2012). Towards regenerative therapy for cardiac disease. Lancet 379, 933-942.
31. Ranganathan, P.V., Jayakumar, C., and Ramesh, G. (2013). Netrin-1-treated macrophages protect the kidney against ischemia-reperfusion injury and suppress inflammation by inducing M2 polarization. Am. J. Physiol. Renal Physiol. 304, F948-F957.
32. Rosenberger, P., Schwab, J.M., Mirakaj, V., et al. (2009). Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflamm ation caused by hypoxia. Nat. Immunol. 10, 195-202.
33. Schaffler, A., and Buchler, C. (2007). Concise review: Adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25, 818-827.
34. Scheubel, R.J., Zorn, H., Silber, R.E., et al. (2003). Agedependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 42, 2073-2080.
35. Shake J.G.,Gruber P.J.,Baumgartner W.A.,et al., 2002, Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann. Th orac. Surg., 73, 1919-1925; discussion 1926.
36. Uemura, R., Xu, M., Ahmad, N., and Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98, 1414-1421.
37. Valina, C., Pinkernell, K., Song, Y.H., et al. (2007). Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 28, 2667-2677.
38. Vicent, D., Ilany, J., Kondo, T., et al. (2003). The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest. 111, 1373-1380.
39. Walter, D.H., Rochwalsky, U., Reinhold, J., et al. (2007). Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler. Thromb. Vasc. Biol. 27, 275 -282.
40. Yan, J., Tie, G., Park, B., et al. (2009). Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial progenitor cells. J. Vasc. Surg. 50, 1412-1422.
41. Zeng, L., Hu, Q., Wang, X., et al. (2007). Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115, 1866-1875.
42. Zhang, J., and Cai, H. (2010). Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism. J. Mol. Cell. Cardiol. 48, 1060-1070.
43. Zhao, Q., Zhang, J., Song, L., et al. (2013). Polysaccharidebased biomaterials with on-demand nitric oxide releasing property regulated by enzyme catalysis. Biomater ials 34, 8450-8458.
44. Zhu, H., Guo, Z.K., Jiang, X.X., et al. (2010). A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc. 5, 550-560.
45. Zimmet, J.M., and Hare, J.M. (2005). Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res. Cardiol. 100, 471-481.